CIPLA
|
|
| BOM : 500087 NSE : CIPLA | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 17,2026 |
|
Price(EOD): ₹ 1,350.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 109,113.59 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| CIPLA | -2.3% | -5.3% | -9.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.4% | -4.5% | 6.5% |
| DIVIS LABORATORIES | 0.1% | -2.5% | -0.1% |
| TORRENT PHARMACEUTICALS | -2.7% | 1.2% | 39.3% |
| DR REDDYS LABORATORIES | -0.5% | -4.7% | -5.4% |
| MANKIND PHARMA | -0.3% | -5.3% | -0.9% |
| LUPIN | -0.3% | 0.6% | 12.3% |
| ZYDUS LIFESCIENCES | -4% | 7.1% | 10.2% |
| AUROBINDO PHARMA | -2.9% | -5.3% | 20.3% |
FUNDAMENTAL ANALYSIS OF CIPLA
[ Q(TTM): Mar2026, Y: Mar2026
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF CIPLA
[As on : Jun 17,2026
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
28.2
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3,869.79 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 3.17
P/B Calculated based on Book Value of Rs 34,369.40 Cr
[Latest Year - Mar2026 - Consolidated Results ] 3.87
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 28,162.60 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
6% 9% 14% |
SHARE PRICE MOMENTUM OF CIPLA
CIPLA vs SENSEX
DEBT OF CIPLA
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2026 2025 2024 Avg_3yrs |
0 0 0 - |
0.01 0 0.01 0.01 |
|
[Last Annual Data : Mar2026]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF CIPLA
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF CIPLA
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-7.54% -20.56% -20.83% -18.45% |
-2.8% -35.16% -53% -55.09% |
| QtrlyTrend |
-8 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
CIPLA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | 4% | 2.8% | -1% |
| BSE 100 | 3.9% | 2.4% | -2.9% |
| BSE 500 | 3.9% | 2.5% | -1.3% |
| BSE 100 ESG INDEX | 3.9% | 2.3% | -2.5% |
| BSE 250 LARGEMIDCAP INDEX | 3.9% | 2.3% | -1.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 EQUAL WEIGHT | 4.1% | 3.6% | 0.5% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 4% | 3.1% | 0.5% |
| NIFTY TOTAL MARKET | 4% | 2.8% | -0.8% |
| NIFTY500 MULTICAP 50:25:25 | 4% | 2.9% | -0.2% |
| NIFTY 500 | 3.9% | 2.6% | -1% |
You may also like the below Video Courses
FAQ about CIPLA
Is CIPLA good for long term investment?
As on Jun 17,2026, the Fundamentals of CIPLA look Strong and hence it may be good for long term investment! See Financial Performance of CIPLA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is CIPLA UnderValued or OverValued?
As on Jun 17,2026, CIPLA is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of CIPLA ?
As on Jun 17,2026, the Intrinsic Value of CIPLA is Rs. 1,238.60 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,278.32
Fair Value [Median EV / Sales Model] : Rs. 1,238.60
Fair Value [Median Price / Sales Model] : Rs. 1,179.74
Estimated Median Fair Value of CIPLA : Rs. 1,238.60
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
